Spectral and quantum-chemical study of properties and structure of 5-hydroxybenzimidazole was written by Zaitsev, B. E.;Gaevskaya, A. E.;Kuznetsov, S. L.;Kuznetsov, Yu. V.;Stolyarova, L. G.;Smirnov, L. D.. And the article was included in Izvestiya Akademi Nauk, Seriya Khimicheskaya in 1992.HPLC of Formula: 101018-70-6 The following contents are mentioned in the article:
The heats of formation of six tautomers of the title compound (I) and their anionic and cationic forms as well as energetic, electronic, and structural characteristics of neutral, protonated, and deprotonated tautomers have been calculated by the MNDO method. According to IR spectra I exists in the hydroxy form as two tautomers in the crystal and in CCl4 or CH3CN solution Marked differences were noted in the electronic absorption spectra in acidic media of benzimidazoles with a benzene ring at C-2 as compared with those having alkyl substituents at this position. Spectral characteristics are given to distinguish mono- and dianionic forms of I derivatives This study involved multiple reactions and reactants, such as 4-((Dimethylamino)methyl)-2-methyl-1H-benzo[d]imidazol-5-ol (cas: 101018-70-6HPLC of Formula: 101018-70-6).
4-((Dimethylamino)methyl)-2-methyl-1H-benzo[d]imidazol-5-ol (cas: 101018-70-6) belongs to imidazole derivatives. Many natural products, especially alkaloids, contain the imidazole ring. These imidazoles share the 1,3-C3N2 ring but feature varied substituents. Imidazole based anticancer drug find applications in cancer chemotherapy. It is used as buffer component for purification of the histidine tagged recombinant proteins in immobilized metal-affinity chromatography (IMAC).HPLC of Formula: 101018-70-6
Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem